Platelet-activating factor induces up-regulation of antiapoptotic factors in a melanoma cell line through nuclear factor-κB activation

Cancer Research

Volumn 66, Issue 9, 2006, Pages 4681-4686

  Kook, Heon Seo ^a   Ko, Hyun Mi ^a,b   Kim, Han A ^a   Choi, Jung Hwa ^a   Sung, Jun Park ^a   Kim, Kyoung Jin ^a   Lee, Hern Ku ^b   Im, Suhn Young ^a  

^a Chonnam National University   (South Korea)

^b Chonbuk National University Medical School   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; ETOPOSIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PARTHENOLIDE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL GROWTH; CELL LINE; CONTROLLED STUDY; DRUG INHIBITION; ENZYME ACTIVITY; FEMALE; GROWTH INHIBITION; IN VIVO STUDY; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; UPREGULATION;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; CASPASES; CELL LINE, TUMOR; DRUG INTERACTIONS; ETOPOSIDE; FEMALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NF-KAPPA B; PLATELET ACTIVATING FACTOR; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; SESQUITERPENES; UP-REGULATION;

EID: 33646392184     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-3186     Document Type: Article

References (49)

1. Hockenbery D. Defining apoptosis. Am J Pathol 1995;146:16-9.
2. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456-62.
3. Kuriyama H, Lamborn KR, O'Fallon JR, et al. Prognostic significance of an apoptotic index and apoptosis/proliferation ratio for patients with high grade astrocytomas. Neuro-oncol 2002;4:179-86.
4. Lipponen P, Aaltomaa S, Kosma VM, Syrjanen K. Apoptosis in breast cancer as related to histopathological characteristics and prognosis. Eur J Cancer 1994;30A:2068-73.
5. Sinicrope FA, Hart J, Hsu HA, Lemoine M, Michelassi F, Stephens LC. Apoptotic and mitotic indices predict survival rates in lymph node-negative colon carcinomas. Clin Cancer Res 1999;5:1793-804.
6. Vindigni C, Miracco C, Spina D, et al. Cell proliferation, cell death and angiogenesis in early and advanced gastric cancer of intestinal type. Int J Cancer 1997;74:637-41.
7. Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med 1997;3:614-20.
8. Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994;124:1-6.
9. Boise LH, Gonzalez-Garcia M, Postema CE, et al. Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993;74:597-608.
10. Fukuda AI, Breuel KF. Effect of platelet-activating factor on embryonic development and implantation in the mouse. Hum Reprod 1996;11:2746-9.
11. Nilsson G, Metcalfe DD, Taub DD. Demonstration that platelet-activating factor is capable of activating mast cells and inducing a chemotactic response. Immunology 2000;99:314-9.
12. Toledano BJ, Bastien Y, Noya F, Mazer B. Characterization of B lymphocytes rescued from apoptosis by platelet-activating factor. Cell Immunol 1999;191:60-8.
13. Toledano BJ, Bastien Y, Noya F, Baruchel S, Mazer B. Platelet-activating factor abrogates apoptosis induced by cross-linking of the surface IgM receptor in a human B lymphoblastoid cell line. J Immunol 1997;158:3705-15.
14. Barber LA, Spandau DF, Rathman SC, et al. Expression of the platelet-activating factor receptor results in enhanced ultraviolet B radiation-induced apoptosis in a human epidermal cell line. J Biol Chem 1998;273:18891-7.
15. Hostettler ME, Knapp PE, Carlson SL. Platelet-activating factor induces cell death in cultured astrocytes and oligodendrocytes: involvement of caspase-3. Glia 2002;38:228-39.
16. Shi LC, Wang HY, Friedman E. Involvement of platelet-activating factor in cell death induced under ischemia/post-ischemia-like conditions in an immortalized hippocampal cell line. J Neurochem 1998;70:1035-44.
17. Reuther-Madrid JY, Kashatus D, Chen S, et al. The p65/RelA subunit of NF-κB suppresses the sustained, antiapoptotic activity of Jun kinase induced by tumor necrosis factor. Mol Cell Biol 2002;22:8175-83.
18. Khreiss T, Jozsef L, Chan JS, Filep JG. Activation of extracellular signal-regulated kinase couples platelet-activating factor-induced adhesion and delayed apoptosis of human neutrophils. Cell Signal 2004;16:801-10.
19. Bussolino F, Arese M, Montrucchio G, et al. Platelet-activating factor produced in vitro by Kaposi's sarcoma cells induces and sustains in vivo angiogenesis. J Clin Invest 1995;96:940-52.
20. Montrucchio G, Sapino A, Bussolati B, et al. Potential angiogenic role of platelet-activating factor in human breast cancer. Am J Pathol 1998;153:1589-96.
21. Biancone L, Cantaluppi V, Del Sorbo L, Russo S, Tjoelker LW, Camussi G. Platelet-activating factor inactivation by local expression of platelet-activating factor acetyl-hydrolase modifies tumor vascularization and growth. Clin Cancer Res 2003;9:4214-20.
22. Im SY, Han SJ, Ko HM, et al. Involvement of nuclear factor-κB in platelet-activating factor-mediated tumor necrosis factor-α expression. Eur J Immunol 1997;27:2800-4.
23. Prewett M, Huber J, Li Y, et al. Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumor. Cancer Res 1999;59:5209-18.
24. Im SY, Ko HM, Ko YS, et al. Augmentation of tumor metastasis by platelet-activating factor. Cancer Res 1996;56:2662-5.
25. Mizumoto K, Rothman RJ, Farber JL. Programmed cell death (apoptosis) of mouse fibroblasts is induced by the topoisomerase II inhibitor etoposide. Mol Pharmacol 1994;46:890-5.
26. Pulliam L, Zhou M, Stubblebine M, Bitler CM. Differential modulation of cell death proteins in human brain cells by tumor necrosis factor α and platelet-activating factor. J Neurosci Res 1998;54:530-8.
27. Southall MD, Isenberg JS, Nakshatri H, et al. The platelet-activating factor receptor protects epidermal cells from tumor necrosis factor (TNF) α and TNF-related apoptosis-inducing ligand-induced apoptosis through an NF-κB-dependent process. J Biol Chem 2001;276:45548-54.
28. Azzouzi B, Jurgens P, Benveniste J, Thomas Y. Immunoregulatory functions of PAF-acether. IX. Modulation of apoptosis in an immature T cell line. Biochem Biophys Res Commun 1993;190:320-4.
29. Wu B, Iwakiri R, Ootani A, Fujise T, Tsunada S, Fujimoto K. Platelet-activating factor promotes mucosal apoptosis via FasL-mediating caspase-9 active pathway in rat small intestine after ischemia-reperfusion. FASEB J 2003;17:1156-8.
30. Chandrasekher G, Ma X Lallier TE, Bazan HEP. Delay of corneal epithelial wound healing and induction of keratocyte apoptosis by platelet-activating factor. Invest Ophthalmol Vis Sci 2002;43:1422-8.
31. Brewer C, Bonin F, Bullock P, et al. Platelet activating factor-induced apoptosis is inhibited by ectopic expression of the platelet activating factor G-protein coupled receptor. J Neurochem 2002;82:1502-11.
32. Wang W, Abbruzzese JL, Evans DB, Larry L, Cleary KR, Chiao PJ. The nuclear factor-κB RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. Clin Cancer Res 1999;5:119-27.
33. Bours V, Dejardin E, Goujon-Letawe F, Merville MP, Castronovo V. The NF-κB transcription factor and cancer: High expression of NF-κB- and IκB-related proteins in tumor cell lines. Biochem Pharmacol 1994; 47:145-9.
34. Dejardin E, Bonizzi G, Bellahcene A, Castronovo V, Merville MP, Bours V. Highly-expressed p100/p52 (NFKB2) sequesters other NF-κB-related proteins in the cytoplasm of human breast cancer cells. Oncogene 1995;11:1835-41.
35. Duffey DC, Chen Z, Dong G, et al. Expression of a dominant-negative mutant inhibitor-κBα of nuclear factor-κB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo. Cancer Res 1999;59:3468-74.
36. Nakshatri H, Bhat-Nakshatri P, Martin DA, Goulet RJ, Jr., Sledge GW, Jr. Constitutive activation of NF-κB during progression of breast cancer to hormone-independent growth. Mol Cell Biol 1997;17:3629-39.
37. Deveraux QL, Roy N, Stennicke HR, et al. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J 1998;17:2215-23.
38. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS, Jr. NF-κB anti-apoptosis: induction of TRAF1 and TRAF2 and C-IAP1 and C-IAP2 to suppress caspase-8 activation. Science 1998;281:1680-3.
39. Baldwin AS, Jr. The NF-κB and IκB proteins: New discoveries and insights. Annu Rev Immunol 1996;14:649-83.
40. Ravi R, Bedi GC, Engstrom LW, et al. Regulation of death receptor expression and TRAIL/Apo2L-induced apoptosis by NF-κB. Nat Cell Biol 2001;3:409-16.
41. Catz SD, Johnson JL. Transcriptional regulation of bcl-2 by nuclear factor κB and its significance in prostate cancer. Oncogene 2001;20:7342-51.
42. Franco AV, Zhang XD, Van Berkel E, et al. The role of NF-κB in TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of melanoma cells. J Immunol 2001;166:5337-45.
43. Ivanov VN, Fodstad O, Ronai Z. Expression of ring finger-deleted TRAF2 sensitizes metastatic melanoma cells to apoptosis via up-regulation of p38, TNFα and suppression of NF-κB activities. Oncogene 2001;20:2243-53.
44. Han SJ, Choi JH, Ko HM, et al. Glucocorticoids prevent NF-κB activation by inhibiting the early release of platelet-activating factor in response to lipopolysaccharide. Eur J Immunol 1999;29:1334-41.
45. Choi JH, Ko HM, Kim JW, et al. Platelet-activating factor-induced early activation of NF-κB plays a crucial role for organ clearance of Candida albicans. J Immunol 2001;166:5139-44.
46. Mencia-Huerta JM, Benveniste J. Platelet-activating factor and macrophage. I. Evidence for the release from rat and mouse peritoneal macrophages and not from mastocytes. Eur J Immunol 1979;9:409-15.
47. Camussi G, Aglietta M, Coda R, Bussolino F, Piacibello W, Tetta C. Release of platelet-activating factor (PAF) and histamine. II. The cellular origin of human PAF: monocytes, polymorphonuclear neutrophils and basophils. Immunology 1981;42:191-9.
48. Pitton C, Lanson M, Besson P, et al. Presence of PAF-acether in human breast carcinoma: relation to axillary lymph node metastasis. J Natl Cancer Inst 1989;81:1298-302.
49. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 2002;23:549-55.